Breaking News

COVID-19 Update: FDA Issues EUA to Hologic and LabCorp

More than 90 test developers have sought FDA guidance for tests they plan to offer through the EUA process

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The U.S. Food and Drug Administration took two additional significant diagnostic actions during the coronavirus outbreak (COVID-19) by issuing Emergency Use Authorizations (EUAs) to: Hologic for its Panther Fusion SARS-COV-2 Assay, and LabCorp for its COVID-19 RT-PCR test.   “Staff at FDA have been working nonstop to expedite the review and authorization of diagnostics during this public health emergency,” said FDA Commissioner Stephen M. Hahn, M.D. “Our device center has been ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters